LORA UTECH: Open Payments
NPI 1831205533 · TOPEKA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,548 in 80 payments from 15 companies in 2025. Trend: 2023 $1,497 · 2024 $1,356 · 2025 $1,548
Food & beverage: $1,548
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 16 | $318 |
| ABBVIE INC. | 18 | $283 |
| Janssen Biotech, Inc. | 11 | $228 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $146 |
| QOL Medical, LLC | 5 | $121 |
| Regeneron Healthcare Solutions, Inc. | 3 | $62 |
| Ardelyx, Inc. | 3 | $57 |
| Lilly USA, LLC | 2 | $57 |
| Aimmune Therapeutics, Inc. | 2 | $54 |
| Ipsen Biopharmaceuticals, Inc | 3 | $53 |
Products named: ENTYVIO, TREMFYA, XIFAXAN, Sucraid, RINVOQ, DUPIXENT, VIBERZI, IBSRELA.
Industry payments across KS — which companies pay providers there.
